vs
Forestar Group Inc.（FOR）与Harmony Biosciences Holdings, Inc.（HRMY）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是Harmony Biosciences Holdings, Inc.的1.1倍（$273.0M vs $243.8M），Harmony Biosciences Holdings, Inc.净利率更高（9.2% vs 5.6%，领先3.6%），Harmony Biosciences Holdings, Inc.同比增速更快（21.1% vs 9.0%），Harmony Biosciences Holdings, Inc.自由现金流更多（$126.0M vs $-157.1M），过去两年Harmony Biosciences Holdings, Inc.的营收复合增速更高（25.6% vs -9.6%）
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
FOR vs HRMY — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.0M | $243.8M |
| 净利润 | $15.4M | $22.5M |
| 毛利率 | 20.1% | 71.9% |
| 营业利润率 | 7.6% | 15.8% |
| 净利率 | 5.6% | 9.2% |
| 营收同比 | 9.0% | 21.1% |
| 净利润同比 | -6.7% | -54.6% |
| 每股收益（稀释后） | $0.30 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $273.0M | $243.8M | ||
| Q3 25 | $670.5M | $239.5M | ||
| Q2 25 | $390.5M | $200.5M | ||
| Q1 25 | $351.0M | $184.7M | ||
| Q4 24 | $250.4M | $201.3M | ||
| Q3 24 | $551.3M | $186.0M | ||
| Q2 24 | $318.4M | $172.8M | ||
| Q1 24 | $333.8M | $154.6M |
| Q4 25 | $15.4M | $22.5M | ||
| Q3 25 | $86.9M | $50.9M | ||
| Q2 25 | $32.9M | $39.8M | ||
| Q1 25 | $31.6M | $45.6M | ||
| Q4 24 | $16.5M | $49.5M | ||
| Q3 24 | $81.5M | $46.1M | ||
| Q2 24 | $38.7M | $11.6M | ||
| Q1 24 | $45.0M | $38.3M |
| Q4 25 | 20.1% | 71.9% | ||
| Q3 25 | 22.3% | 75.1% | ||
| Q2 25 | 20.4% | 81.0% | ||
| Q1 25 | 22.6% | 82.7% | ||
| Q4 24 | 22.0% | 73.0% | ||
| Q3 24 | 23.9% | 77.0% | ||
| Q2 24 | 22.5% | 81.4% | ||
| Q1 24 | 24.9% | 82.2% |
| Q4 25 | 7.6% | 15.8% | ||
| Q3 25 | 16.9% | 27.3% | ||
| Q2 25 | 11.2% | 24.0% | ||
| Q1 25 | 11.6% | 30.4% | ||
| Q4 24 | 8.7% | 27.7% | ||
| Q3 24 | 19.7% | 33.2% | ||
| Q2 24 | 16.2% | 12.4% | ||
| Q1 24 | 17.6% | 33.7% |
| Q4 25 | 5.6% | 9.2% | ||
| Q3 25 | 13.0% | 21.2% | ||
| Q2 25 | 8.4% | 19.8% | ||
| Q1 25 | 9.0% | 24.7% | ||
| Q4 24 | 6.6% | 24.6% | ||
| Q3 24 | 14.8% | 24.8% | ||
| Q2 24 | 12.2% | 6.7% | ||
| Q1 24 | 13.5% | 24.8% |
| Q4 25 | $0.30 | $0.38 | ||
| Q3 25 | $1.70 | $0.87 | ||
| Q2 25 | $0.65 | $0.68 | ||
| Q1 25 | $0.62 | $0.78 | ||
| Q4 24 | $0.32 | $0.85 | ||
| Q3 24 | $1.59 | $0.79 | ||
| Q2 24 | $0.76 | $0.20 | ||
| Q1 24 | $0.89 | $0.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $775.3M |
| 总债务越低越好 | $793.2M | $163.7M |
| 股东权益账面价值 | $1.8B | $870.2M |
| 总资产 | $3.2B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.19× |
8季度趋势，按日历期对齐
| Q4 25 | $211.7M | $775.3M | ||
| Q3 25 | $379.2M | $672.6M | ||
| Q2 25 | $189.2M | $565.3M | ||
| Q1 25 | $174.3M | $507.0M | ||
| Q4 24 | $132.0M | $467.2M | ||
| Q3 24 | $481.2M | $410.5M | ||
| Q2 24 | $359.2M | $346.9M | ||
| Q1 24 | $416.2M | $372.4M |
| Q4 25 | $793.2M | $163.7M | ||
| Q3 25 | $802.7M | $168.5M | ||
| Q2 25 | $872.8M | $172.1M | ||
| Q1 25 | $872.5M | $175.7M | ||
| Q4 24 | $806.8M | $179.3M | ||
| Q3 24 | $706.4M | $182.8M | ||
| Q2 24 | $706.1M | $186.4M | ||
| Q1 24 | $705.7M | $190.0M |
| Q4 25 | $1.8B | $870.2M | ||
| Q3 25 | $1.8B | $835.1M | ||
| Q2 25 | $1.7B | $773.1M | ||
| Q1 25 | $1.6B | $720.5M | ||
| Q4 24 | $1.6B | $659.2M | ||
| Q3 24 | $1.6B | $596.8M | ||
| Q2 24 | $1.5B | $538.6M | ||
| Q1 24 | $1.5B | $515.4M |
| Q4 25 | $3.2B | $1.3B | ||
| Q3 25 | $3.1B | $1.2B | ||
| Q2 25 | $3.1B | $1.1B | ||
| Q1 25 | $3.0B | $1.1B | ||
| Q4 24 | $3.0B | $999.2M | ||
| Q3 24 | $2.8B | $928.1M | ||
| Q2 24 | $2.7B | $858.4M | ||
| Q1 24 | $2.6B | $847.0M |
| Q4 25 | 0.44× | 0.19× | ||
| Q3 25 | 0.45× | 0.20× | ||
| Q2 25 | 0.52× | 0.22× | ||
| Q1 25 | 0.53× | 0.24× | ||
| Q4 24 | 0.50× | 0.27× | ||
| Q3 24 | 0.44× | 0.31× | ||
| Q2 24 | 0.47× | 0.35× | ||
| Q1 24 | 0.48× | 0.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $126.2M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | $126.0M |
| 自由现金流率自由现金流/营收 | -57.5% | 51.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | -10.19× | 5.61× |
| 过去12个月自由现金流最近4个季度 | $93.0M | $347.9M |
8季度趋势，按日历期对齐
| Q4 25 | $-157.0M | $126.2M | ||
| Q3 25 | $256.3M | $108.7M | ||
| Q2 25 | $15.8M | $79.3M | ||
| Q1 25 | $-19.8M | $34.0M | ||
| Q4 24 | $-450.0M | $75.6M | ||
| Q3 24 | $119.2M | $70.5M | ||
| Q2 24 | $-61.7M | $42.6M | ||
| Q1 24 | $-59.2M | $31.1M |
| Q4 25 | $-157.1M | $126.0M | ||
| Q3 25 | $255.6M | $108.7M | ||
| Q2 25 | $15.0M | $79.3M | ||
| Q1 25 | $-20.5M | $33.9M | ||
| Q4 24 | — | $75.0M | ||
| Q3 24 | $118.4M | $70.5M | ||
| Q2 24 | $-62.3M | $42.0M | ||
| Q1 24 | $-59.8M | $31.1M |
| Q4 25 | -57.5% | 51.7% | ||
| Q3 25 | 38.1% | 45.4% | ||
| Q2 25 | 3.8% | 39.6% | ||
| Q1 25 | -5.8% | 18.3% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | 21.5% | 37.9% | ||
| Q2 24 | -19.6% | 24.3% | ||
| Q1 24 | -17.9% | 20.1% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.2% | 0.4% | ||
| Q1 24 | 0.2% | 0.0% |
| Q4 25 | -10.19× | 5.61× | ||
| Q3 25 | 2.95× | 2.14× | ||
| Q2 25 | 0.48× | 1.99× | ||
| Q1 25 | -0.63× | 0.75× | ||
| Q4 24 | -27.27× | 1.53× | ||
| Q3 24 | 1.46× | 1.53× | ||
| Q2 24 | -1.59× | 3.68× | ||
| Q1 24 | -1.32× | 0.81× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
HRMY
暂无分部数据
